Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeimet, A. G.
Right arrow Articles by Marth, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeimet, A. G.
Right arrow Articles by Marth, C.

Journal of Clinical Oncology, Vol 16, 1861-1868, Copyright © 1998 by American Society of Clinical Oncology


ARTICLES

Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer

AG Zeimet, M Widschwendter, C Knabbe, D Fuchs, M Herold, E Muller-Holzner, G Daxenbichler, FA Offner, O Dapunt and C Marth
Department of Obstetrics and Gynecology, University Hospital, University of Innsbruck, Austria. alain.zeimet@uibk.ac.at

PURPOSE: The clinical impact of endogenous cytokines supplied with deterministic properties in the generation of either T helper (Th)1 - type or Th2-type immune response was investigated in patients with ovarian cancer. Whereas interleukin (IL)- 12 initiates the differentiation of naive Th0 cells toward Th1 phenotype, IL-4 and IL-10 mediate the development of Th2-type immunity. PATIENTS AND METHODS: Cytokines were determined before treatment by means of enzyme-linked immunosorbent assay (ELISA) in ascites fluid and serum of 76 patients with ovarian cancer. Cytokine levels were compared with each other and with standard clinicopathologic parameters. A stepwise logistic regression was calculated to rule out interdependence in the associations of the various variables. Survival analyses were performed with the Kaplan-Meier method and differences in survival were examined according to Mantel and Breslow. Cox proportional hazards analysis was used to identify independent prognostic factors. RESULTS: Whereas IL-10 and IL-12 were detectable in all ascites-fluid samples, IL-4 was measurable in only 43% of the specimens. With the exception of neopterin, macrophage colony-stimulating factor (M-CSF), and IL-4, determined cytokine levels were significantly elevated in ascites fluid compared with serum (P < .01). In univariate analyses, high ascitic- fluid concentrations of either neopterin, tumor necrosis factor-alpha (TNF-alpha), or IL-12 were associated with poor disease-free (P < .005) and overall (P < .01) survival. Multivariate Cox regression analysis showed ascitic-fluid IL-12 levels to be the only immunologic variable that retained independent prognostic significance (P < .03 for disease- free and P < .01 for overall survival), together with residual disease, Federation Internationale de Gynecologie et d'Obstetrique (FIGO)-stage, and patient age. CONCLUSION: In ovarian cancer, high ascitic-fluid IL- 12 levels, which may indicate a local Th1-generated immune response, are associated with disease progression.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
L. A. Hefler, N. Concin, G. Hofstetter, C. Marth, A. Mustea, J. Sehouli, R. Zeillinger, H. Leipold, H. Lass, C. Grimm, et al.
Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer
Clin. Cancer Res., February 1, 2008; 14(3): 710 - 714.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. W. Ott, H. Lindner, B. Sarg, E. Mueller-Holzner, B. Abendstein, A. Bergant, S. Fessler, P. Schwaerzler, A. Zeimet, C. Marth, et al.
Calgranulins in Cystic Fluid and Serum from Patients with Ovarian Carcinomas
Cancer Res., November 1, 2003; 63(21): 7507 - 7514.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. V. Cronauer, S. Stadlmann, H. Klocker, B. Abendstein, I. E. Eder, H. Rogatsch, A. G. Zeimet, C. Marth, and F. A. Offner
Basic Fibroblast Growth Factor Synthesis by Human Peritoneal Mesothelial Cells : Induction by Interleukin-1
Am. J. Pathol., December 1, 1999; 155(6): 1977 - 1984.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Tanaka, H. Sugiura, R. Inaba, A. Nishikawa, A. Murakami, K. Koshimizu, and H. Ohigashi
Immunomodulatory action of citrus auraptene on macrophage functions and cytokine production of lymphocytes in female BALB/c mice
Carcinogenesis, August 1, 1999; 20(8): 1471 - 1476.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1998 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online